Orthocell Limited (ASX:OCC)
0.7650
-0.0100 (-1.29%)
May 29, 2026, 4:10 PM AEST
Orthocell Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Orthocell stock has a consensus rating of "Strong Buy" and an average price target of $1.25. The average 1-year stock price forecast is 63.40% higher than the current stock price, while the lowest is $1.24 (+62.09%) and the highest is $1.26 (+64.71%).
Price Target: $1.25 (+63.40%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 21, 2026.
Analyst Ratings
The average analyst rating for Orthocell stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Brenton Anderson Bell Potter No rating | Bell Potter | Buy Maintains $1.15 → $1.24 | Buy | Maintains | $1.15 → $1.24 | +62.09% | Apr 21, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1.33 → $1.26 | Buy | Maintains | $1.33 → $1.26 | +64.71% | Apr 20, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.